Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Assets: 2010-2024

Historic Assets for Sunshine Biopharma (SBFM) over the last 12 years, with Dec 2024 value amounting to $30.6 million.

  • Sunshine Biopharma's Assets rose 4.76% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 million, marking a year-over-year increase of 4.76%. This contributed to the annual value of $30.6 million for FY2024, which is 11.75% up from last year.
  • Sunshine Biopharma's Assets amounted to $30.6 million in FY2024, which was up 11.75% from $27.3 million recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Assets registered a high of $30.6 million during FY2024, and its lowest value of $1.0 million during FY2020.
  • Its 3-year average for Assets is $29.1 million, with a median of $29.2 million in 2022.
  • In the last 5 years, Sunshine Biopharma's Assets surged by 1,227.52% in 2022 and then fell by 6.49% in 2023.
  • Sunshine Biopharma's Assets (Yearly) stood at $1.0 million in 2020, then skyrocketed by 110.71% to $2.2 million in 2021, then soared by 1,227.52% to $29.2 million in 2022, then decreased by 6.49% to $27.3 million in 2023, then increased by 11.75% to $30.6 million in 2024.